Revenue: The sum of all revenue fields included for a company's operating activities.
X4 Pharmaceuticals, Inc. (XFOR) had Revenue of $1.97M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
|
Revenue |
$1.97M |
$-25.74M |
|
$0.33M |
|
$1.65M |
|
$28.20M |
|
$-26.23M |
|
$0.53M |
|
$-25.70M |
|
$-25.70M |
|
$-25.74M |
|
$-25.74M |
|
$-25.74M |
|
$-25.74M |
|
$-26.23M |
|
$-25.88M |
|
7.41M |
|
7.41M |
|
$-3.47 |
|
$-3.47 |
|
| Balance Sheet Financials | |
$72.94M |
|
$0.25M |
|
$32.23M |
|
$105.17M |
|
$22.90M |
|
$75.84M |
|
$78.30M |
|
$101.20M |
|
$3.97M |
|
$-23.00M |
|
$3.97M |
|
7.96M |
|
| Cash Flow Statement Financials | |
$-42.27M |
|
$19.97M |
|
$5.63M |
|
$56.48M |
|
$40.02M |
|
$-16.45M |
|
$1.27M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.19 |
|
-- |
|
-- |
|
0.95 |
|
19.10 |
|
83.48% |
|
-1329.55% |
|
-1329.55% |
|
-- |
|
-1302.79% |
|
-1304.66% |
|
$-42.27M |
|
-- |
|
-- |
|
-- |
|
0.02 |
|
0.10 |
|
1.06 |
|
85.07 |
|
-648.23% |
|
111.89% |
|
-24.48% |
|
-32.25% |
|
$0.50 |
|
$-5.70 |
|
$-5.70 |
|